Abnormal central control underlies impaired baroreflex control of heart rate and sympathetic nerve activity in female Lewis polycystic kidney rats

Journal of Hypertension

Volumn 33, Issue 7, 2015, Pages 1418-1428

  Salman, Ibrahim M ^a   Phillips, Jacqueline K ^a   Ameer, Omar Z ^a   Hildreth, Cara M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Aortic depressor nerve; Baroreflex; Chronic kidney disease; Heart rate; Hypertension; Renal sympathetic nerve

Indexed keywords

CREATININE; PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; EFFERENT NERVE; FEMALE; HEART RATE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LPK RAT; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PULSE PRESSURE; RAT; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; VAGUS NERVE STIMULATION; ADRENERGIC SYSTEM; ANIMAL; AORTA; AUTONOMIC NERVE; CHRONIC KIDNEY FAILURE; HYPERTENSION; INNERVATION; KIDNEY; LEWIS RAT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AORTA; AUTONOMIC PATHWAYS; BAROREFLEX; BLOOD PRESSURE; FEMALE; HEART RATE; HYPERTENSION; KIDNEY; POLYCYSTIC KIDNEY DISEASES; RATS; RATS, INBRED LEW; RENAL INSUFFICIENCY, CHRONIC; SYMPATHETIC NERVOUS SYSTEM; VAGUS NERVE STIMULATION;

EID: 84940884386     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000572     Document Type: Article

References (31)

1. Dursun B, Demircioglu F, Varan HI, Basarici I, Kabukcu M, Ersoy F, et al. Effects of different dialysis modalities on cardiac autonomic dysfunctions in end-stage renal disease patients: one year prospective study. Ren Fail 2004; 26:35-38.
2. Rubinger D, Backenroth R, Sapoznikov D. Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation. Nephrol Dial Transplant 2009; 24:1305-1313.
3. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 2003; 14:425-430.
4. Neumann J, Ligtenberg G, Klein IHT, Boer P, Oey PL, Koomans HA, et al. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 2007; 49:506-510.
5. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105:1354-1359.
6. Mircoli L, Rivera R, Bonforte G, Fedele L, Genovesi S, Surian M, et al. Influence of left ventricular mass, uremia and hypertension on vagal tachycardic reserve. J Hypertens 2003; 21:1547-1553.
7. Johansson M, Gao SA, Friberg P, Annerstedt M, Bergstrom G, Carlstrom J, et al. Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure[ast]. Am J Hypertens 2005; 18:995-1000.
8. Johansson M, Gao SA, Friberg P, Annerstedt M, Carlstrom J, Ivarsson T, et al. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J Hypertens 2007; 25:163-168.
9. Tinucci T, Abrahao SB, Santello JL, Mion D Jr. Mild chronic renal insufficiency induces sympathetic overactivity. J Hum Hypertens 2001; 15:401-406.
10. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69:375-382.
11. Xu R, Zhang L-X, Zhang P-H, Wang F, Zuo L, Wang H-Y. Gender differences in age-related decline in glomerular filtration rates in healthy people and chronic kidney disease patients. BMC Nephrol 2010; 11:20.
12. Franczyk-Skora B, Gluba A, Banach M, Kozlowski D, Malyszko J, Rysz J. Prevention of sudden cardiac death in patients with chronic kidney disease. BMC Nephrol 2012; 13:162.
13. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, et al. US renal data system 2013 annual data report. Am J Kidney Dis 2014; 63 (Suppl 1):A7.
14. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gender Med 2008; 5 (Suppl A):S3-S10.
15. Bavanandan S, Ajayi S, Fentum B, Paul SK, Carr SJ, Robinson TG. Cardiac baroreceptor sensitivity: a prognostic marker in predialysis chronic kidney disease patients? Kidney Int 2005; 67:1019-1027.
16. McCooke JK, Appels R, Barrero RA, Ding A, Ozimek-Kulik JE, Bellgard MI, et al. A novel mutation causing nephronophthisis in the Lewis polycystic kidney rat localises to a conserved RCC1 domain in Nek8. BMC Genomics 2012; 13:393.
17. Phillips JK, Hopwood D, Loxley RA, Ghatora K, Coombes JD, Tan YS, et al. Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease. Kidney Blood Press Res 2007; 30:129-144.
18. Salman IM, Hildreth CM, Ameer OZ, Phillips JK. Differential contribution of afferent and central pathways to the development of baroreflex dysfunction in chronic kidney disease. Hypertension 2014; 63:804-810.
19. Ng K, Hildreth CM, Phillips JK, Avolio AP. Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model. Am J Physiol 2011; 300:F1431-F1436.
20. Ameer OZ, Salman IM, Avolio AP, Phillips JK, Butlin M. Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension. Am J Physiol Heart Circ Physiol 2014; 307:H143-H151.
21. Hildreth CM, Kandukuri DS, Goodchild AK, Phillips JK. Temporal development of baroreceptor dysfunction in a rodent model of chronic kidney disease. Clin Exp Pharmacol Physiol 2013; 40:458-465.
22. Studinger P, Lenard Z, Mersich B, Reusz GS, Kollai M. Determinants of baroreflex function in juvenile end-stage renal disease. Kidney Int 2006; 69:2236-2242.
23. Chan CT, Jain V, Picton P, Pierratos A, Floras JS. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 2005; 68:338-344.
24. Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 2005; 20:1140-1147.
25. Minami N, Head GA. Cardiac vagal responsiveness during development in spontaneously hypertensive rats. Auton Neurosci 2000; 82:115-122.
26. Mace SE, Levy MN. Neural control of heart rate: a comparison between puppies and adult animals. Pediatr Res 1983; 17:491-495.
27. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, et al. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011; 57:846-851.
28. Lacy P, Carr SJ, O'Brien D, Fentum B, Williams B, Paul SK, et al. Reduced glomerular filtration rate in predialysis nondiabetic chronic kidney disease patients is associated with impaired baroreceptor sensitivity and reduced vascular compliance. Clin Sci (Lond) 2006; 110:101-108.
29. Harris DC, Rangan GK. Retardation of kidney failure-applying principles to practice. Ann Acad Med Singapore 2005; 34:16-23.
30. Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G. Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol 2006; 17 (4 Suppl 2):S98-S103.
31. Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int 2000; 58:2147-2154.